Respiratory Infection Rapid Antigen Test Manufacturer
CE marked colloidal gold lateral flow antigen tests for Influenza A/B, COVID-19, and RSV. Fast, accurate point-of-care testing solutions for pharmacies, clinics, and healthcare facilities worldwide.
Colloidal Gold Antigen Tests for Respiratory Infections
Our respiratory disease rapid test range uses lateral flow immunoassay (LFIA) technology with colloidal gold conjugates to detect viral antigens directly from nasopharyngeal or nasal swab samples. Results are available in 15 minutes, enabling rapid clinical decision-making without laboratory instrumentation.
These immunochromatographic antigen tests are ideal for point-of-care testing (POCT) in pharmacies, clinics, and screening programs. Available as single-target tests or combination panels for simultaneous Influenza A/B and COVID-19 detection.
Respiratory Test Product Range
Influenza A/B Antigen
Rapid flu detection for seasonal screening
COVID-19 Antigen
SARS-CoV-2 rapid antigen test
RSV Antigen
Respiratory syncytial virus detection
Flu + COVID Combo Test
3-in-1 respiratory panel for simultaneous detection
Applications & Use Cases
- Pharmacy point-of-care testing
- Private clinics and urgent care centers
- School and workplace health screening
- Travel screening checkpoints
- Hospital emergency departments
- Home testing distribution
Sample Types
Key Features
- • 15-minute results
- • No equipment required
- • Self-test kits available
- • Room temperature storage
Quality Certifications
Our respiratory tests meet international regulatory standards
Source Respiratory Rapid Tests for Your Market
OEM/ODM manufacturing and bulk supply for distributors in Europe, Southeast Asia, and the Middle East.